Tizanidine Tablet
Product Images NDC 68071-3440

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 68071-3440). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3440 9)

Label for Tizanidine 2 mg oral tablets by NuCare Pharmaceuticals, Inc. The label states 90 tablets per package and identifies the product as prescription only. It describes the tablet as oval, flat, beveled edge, white to off-white, debossed with R179 and a bisecting score. Manufacturer information includes Dr. Reddy's Laboratories Limited in India.*

FDA Label Image

Fig1 (Fig1)

A line graph showing plasma Tizanidine concentration (ng/mL) over time (hours) from dosing, comparing 2 x 4 mg Tizanidine tablets and capsules taken with and without food. The graph displays four curves labeled for tablets and capsules with and without food, illustrating differences in Tizanidine plasma levels within 24 hours after dosing.*

FDA Label Image

Fig2 (Fig2)

A line graph showing improvement in Ashworth Score over 6 hours post-dose comparing 16 mg tizanidine, 8 mg tizanidine, and placebo. The vertical axis represents improvement in Ashworth Score, and the horizontal axis represents hours post-dose from 0 to 6. Error bars indicate variability around each data point.*

FDA Label Image

Fig3 (Fig3)

A line graph comparing improvement in Ashworth Score over time between tizanidine (mean dose 28.8 mg) and placebo groups. The x-axis shows time points: End of Titration (Study Week 3), End of Maintenance (Study Week 7), and Endpoint (Last Observation Carried Forward). The y-axis measures improvement in Ashworth Score, ranging from -6 to 2. Error bars indicate variability at each time point for both groups.*

FDA Label Image

Structure (Structure)

Chemical structure of Tizanidine hydrochloride, showing the molecular formula arrangement associated with the active pharmaceutical ingredient in the product.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.